Data on the epidemiology of severe infection in the intensive care unit (ICU) can be used to monitor the effect of preventive measures and changes in policy or procedures. The most common risk factors associated with ICU-acquired infection include length of stay, antibiotic usage, catheterization and use of other invasive devices. The most frequent infections encountered in ICU patients include lower respiratory tract infections (especially pneumonia) and bacteremia, in addition to urinary tract infections and wound infections. Streptococcus pneumoniae, Haemophilus influenzae, methicillinsusceptible Staphylococcus aureus and Enterobacteriaceae are most often implicated in community-acquired and early onset ICU-acquired infections, whereas late onset infection is more likely t o be caused by pathogens which are more refractory to treatment, such as Enterobacter spp., Serratia spp., Pseudomonas aeruginosa, Acinetobacter spp. and methicillin-resistant S. aureus (MRSA). The pathogen spectrum also varies according t o the site of infection, with Grampositive bacteria being most frequently isolated in bacteremia and wound infections, whereas Gram-negative bacteria are prevalent in late-onset pneumonia and urinary tract infections. The prevalence of Gram-positive pathogens in bacteremia has increased over the past 20 years, mainly because of the increased isolation of coagulase-negative staphylococci (CNS) and enterococci. This is most probably due to the selective pressure exerted by the use of broad-spectrum antibiotics, such as the third-generation cephalosporins and fluoroquinolones, which are generally more potent against Gramnegative than Gram-positive bacteria, and to the increased use of invasive devices.
INTRODUCTION
Adequate infection control and antibiotic prescribing policies rely on data based on the epidemiology of infections. Patients in the intensive care unit (ICU) may be admitted with community-acquired infection or may become infected after admission.
However, the definition of the concept of community-compared with hospital-acquired infection may be challenged in some clinical settings since more patients, such as HIV positive or other immunocompromized patients. For example, a high fi-equency of apparent 'community-acquired' infections caused by Pseudomonas aevuginosa has been reported recently [l] . Many of these patients were probably contaminated with hospital strains in day-care facilities or during previous hospital stays. In addition, the definition of early versus late nosocomial-acquired infections has been more or less arbitrary [2, 3] .
Nosocomial infection is associated with increased mortality, morbidity, length of hospital stay and cost of treatment [4]. In a matched case-control study of surgical ICU patients, the crude mortality of patients with nosocomial bloodstream infection was 50% and the attributable mortality due to the infection was 35% (95% CI 5 25-45%) [ 5 ] . Cases with bloodstream S36 Wolff: The changing epidemiology of severe infections i n t h e ICU s37 infection stayed eight days longer in the ICU and 24 days longer in hospital than matched controls without infection, with associated attributable costs of more than US $40,000 per survivor. Similar results have been found in other studies of nosocomial infections, highlighting the economic importance of adequate management of patients with sepsis [6] .
Critically ill patients are at higher risk of acquiring infection because of more serious underlying conditions and greater use of invasive procedures [7] . The important parameters that need to be monitored are: the predominant types of infection encountered in I C U patients, risk factors associated with the acquisition of these infections, pathogen prevalence and the transfer between ICUs (within and outside the hospital) and the antibiotic susceptibilities of these pathogens. A number of recent reports have examined the epidemiology of serious infections in I C U patients [8-141 and the current situation is discussed in this paper.
RISK FACTORS FOR INFECTION IN THE ICU
The results of the European Prevalence of Infection in Intensive Care (EPIIC) study, the first large study in Europe to examine the prevalence of nosocomial infection and associated risk factors in ICU, were published in 1995 [8] . The study included 4501 patients who had one or more infections on the study day (44.8% of the total patient population). Community-acquired infection was recorded in 1376 cases (13.7%), hospital-acquired infection in 975 (9.7%) and ICU-acquired infection in 2064 cases (20.6%) of the total patient population.
Although there was a marked variation in the incidence of infection in the 17 countries participating in EPIIC, a significant correlation (R2 = 0.68) was noted between the prevalence of ICU-acquired infection and the mortality rate; likewise, mortality was linked with acquired pneumonia, bacteremia and sepsis after multivariate analysis. Predisposing risk factors associated with ICU-acquired infection were: prolonged length of I C U stay, antibiotic usage, mechanical ventilation, pulmonary artery catheterization, central venous access, stress ulcer prophylaxis, urinary catheterization, the use of steroids and nutritional status. Thus, many factors may influence the microbial etiology of sevsere infections in ICU. This paper will focus on the length of stay, that is the duration of exposure to risk, arid on the usage of antibiotics. Risk factors such as mechanical ventilation and neutropenia will be discussed later in the supplement [15, 16] .
Duration of stay
The length of stay in the ICU is a major risk factor for all nosocomial infections [7] . In the EPIIC study, patients who had been in the ICU for 3-4 days were three times more likely to acquire an infection than those who had been admitted for 1-2 days. The risk increased two-fold for patients who had been in the ICU for 5-6 days and those who had been in the ICU for a t least 21 days were 33 times more likely to be infected than those who had been there for 1-2 days [8] .
The duration of stay in the ICU also influences the pathogens involved. In general, community-acquired infections and early hospital-acquired infections (i.e. those acquired I 4 days after admission) are more often caused by Streptococcus pneumoniae, Haemophilus injuenzae, Enterobacteriaceae such as Escherichia coli, Proteus spp. and Klebsiella pneumoniae, methicillinsusceptible Staphylococcus aureus, streptococci and anaerobes. In contrast, late hospital-acquired infections (acquired > 4 days after admission) are more often due to high-risk resistant organisms such as Entevobacter spp., Serratia spp., organisms producing extended-spectrum p-lactamases (ESBLs) , P. aeruginosa, Acineto6acter spp., methicillin-resistant Staphylocoi-cus auveus, enterococci and fungi [2] . In a recent outbreak of ESBL-producing Enterobacteriaceae in a French ICU, it was shown that the risk for acquiring these pathogens increased during the ICU stay from 4.2% in the first week to 24% in the fourth week [17] .
Antibiotic usage
There is no doubt that increasing antimicrobial resistance has followed the introduction of new antibiotics [18] [19] [20] [21] [22] [23] [24] [25] and many nosocomial organisms have acquired multidrug resistance. The prevalence of antimicrobial-resistant human pathogens is rapidly increasing, but the discovery and development of new antibacterial agents that are active against multidrugresistant organisms have slowed dramatically [26] . Critically ill patients constitute major reservoirs for multi-resistant organisms and resistance spread is common in ICUs where the majority of outbreaks of nosocomial transmission have been described. The issue of resistance in nosocomial pathogens is covered in more detail elsewhere in this supplement [25] .
Previous exposure to antibiotics may favor the emergence of multi-resistant pathogens by two main mechanisms. Firstly, antibiotics may modift. intestinal flora, leading to colonization with resistant bacteria. For example, third-generation cephalosporins [27] , fluoroquinolones and vanconiycin [28] have been found to be risk factors for colonization and/or infection with vancomycin-resistant enterococci. Secondly, antibiotics may favor the selection of inducible P-lactamase producing Gram-negative bacilli such as P. aeruginosa, E. cloacae, Serratia spp. and Citrobacter freundii. Using a prospective, casecontrolled observational study, Jacobson et al. (1995) have recently examined the risk factors for the development of resistance to extended-spectrum cephalosporins in the Bush Group 1 (inducible AmpC) P-lactamase producing organisms [29] . Prior use and the mean number of antibiotics used were significantly greater for resistant compared to susceptible isolates (3.2 vs. 1.8; p < 0.032). Resistance was associated with prior use of ceftizoxime or cefotaxime (p = 0.008), ceftazidime (p = 0.004) and piperacillin (p = 0.001). In this study, there was also a linear relationship between the number of days of antibiotic therapy and the risk of developing resistance.
In the EPIIC study, 62% of 10,038 patients were receiving antibiotics for either prophylaxis or treatment on the study day. The most frequently administered antibiotics were cephalosporins (44%) followed by broad-spectrum penicillins (24.3%), aminoglycosides (23.9%), metronidazole (17.1%), fluoroquinolones (1 1.9%) and glycopeptides (1 1.6%). Of the patients receiving antimicrobials, 5 1% received more than one agent.
Antibiotic usage and prescribing policy play a very important role in the epidemiology of nosocomial infections in the ICU. A study from 1993 [30] found that, in patients who did not receive antibiotic treatment prior to their pneumonic episode, the predominant pathogens were methicilhn-susceptible S. aureus, H. influenzae and S. pneumoniae. In contrast, considering patients who had received antibiotic therapy prior to the onset of pneumonia, the predominant pathogens were P. aeruginosa, S. aureus and S . marcescens (Table 1) . Overall, a significant difference was seen in the prevalence of Grampositive cocci, which represented 49.1% of isolates in the group with no prior exposure to antibiotics, compared with 13.4% of isolates in the group exposed to previous antibiotic therapy. In contrast, Gramnegative bacilli, excluding H . influenzae, represented 19.6% ofisolates in patients not exposed to antibiotics, compared with 69.2% of isolates from patients with prior antibiotic exposure. The major risk factor for mortality in ventilator-associated pneumonia (VAP) was prior antibiotic use (OR = 9.2), but when the etiological agent was included in the regression equation, prior antibiotic use was no longer a significant risk factor [30] . This demonstrated that the different distribution of microorganisms present in patients who had received prior antibiotic therapy was the true risk factor, and that a higher mortality rate was associated with certain high-risk pathogens such as P. aeruginosa [30] .
In a recent study, the pathogens responsible for VAP were examined in relation to the duration of ventilation and prior antibiotic exposure [3 11. Pseudomonas spp., Acinetobacter spp. and MRSA were more prevalent in patients who were previously exposed to antimicrobials. In contrast, MRSA and S. pneumoniae were more frequently isolated from patients who had not received prior antibiotics. Prior antibiotic exposure &d not appear to affect the prevalence of Enterobacteriaceae or Haemophilus spp., but the frequency of isolation of Haemophilus spp. decreased markedly in patients who had been ventilated for longer than 7 days [31] . Furthermore, in a matched case-control study, the mortality rate for nosocomial Gram-negative bacilli a Patients from medical-surgical ICU. b Patients received broad-spectrum antibiotics for more than 48 h in the 10 days preceeding a pneumonic episode.
pneumonia caused by pathogens such as Pseudomonas spp. and Acinetobucter spp., was higher than for the more antibiotic-susceptible pathogens, with an attributable rate of up to 43%, compared with 27% for other pathogens [32] . In the study by Rello et al. [30] , variables associated with mortality in VAP were found to be age (> 45 years), the use of corticosteroids, shock, hospital day of acquiring VAP > day 9, antecedent chronic obstructive pulmonary disease (COPD) and prior antibiotic use.
The prognosis in patients with bacteremic sepsis depends on the severity of acute illness, underlying chronic diseases and complications associated with infection. In a cohort of 176 surgical ICU patients presenting with sepsis and positive blood cultures [33] , independent predictors of mortality at onset of sepsis were exposure to previous antibiotic therapy (OR = 2.40, CI,, 1.59-3.62, p = 0.034), hypothermia (OR = 1.43, CI,, 1.04-2.44, p = 0.030), requirement for mechanical ventilation (OR = 2.97, CI,, 1.96-4.51, p = 0.009) and onset-of-sepsis APACHE I1 score (OR = 1.21, CI,, 1.13-1.29, p < 0.001). Vital organ dysfunction developing after the onset of sepsis influenced outcome markedly. Thus, exposure to antimicrobials at the time of bacterema is associated with poor outcome, even after adjustment for other factors.
Catheterization
A major factor responsible for infection in the ICU is the greater usage of multiple invasive devices, particularly in critically ill patients. A recent study found that 25% of episodes of bacteremia were due to catheter-associated infections and primary bacteremia accounted for 18% of episodes of severe sepsis [13] . Catheter-associated bloodstream infections are increasing in incidence and are frequently caused by coagulase-negative staphylococci (CNS) which enter frorn the patient's skin on insertion or from flora on the hands of medical personnel during subsequent manipulation of the intravenous line. Indeed, recent data demonstrated that the proportion of C N S responsible for nosocomial bloodstream infections was more than twice that of CNS responsible for community-acquired infection [9] . The increased use of indwelling devices has also been shown to be a risk factor for the acquisition of nosocomial candidemia [34-361. 
CURRENT EPIDEMIOLOGY
Over recent years, changes in the distribution of organisms and drug resistance patterns have emerged among nosocomial pathogens [32, 37] . The distribution and frequency of pathogens vary, both with the site of infection and the hospital location. Surveillance information is therefore vital in order to determine local and national trends in the incidence of the major pathogens and their antimicrobial susceptibility [25] .
Large epidemiological studies
Results from the National Nosocomial Infection Surveillance (NNIS) study, generated by 80 medical centers in the USA from 1980-1992, indicate a trend towards fewer urinary tract infections and more bloodstream infections in the hospital environment [ll] . This may be related to changes in urinary catheter care and to the increasing use of intravascular devices. Pneumonia and primary bacteremia were among the most serious hospital-acquired infections, accounting for greater than 15% and 13% of infections, respectively. The incidence of bacteremia increased from 7% in 1980 to 13% in 1992, whereas the incidence of urinary tract infections fell from 40% to 33% over the same time period.
These findings were also confirmed in international studies [8] . O n the day of the EPIIC study, the most prevalent ICU-acquired infection was pneumonia, which accounted for 47% of infections followed by lower respiratory tract infections other than pneumonia, urinary tract infections, bacteremia and wound infections ( Figure 1) [8].
Distribution of pathogens
In the NNIS study, among hospitals conducting ICU surveillance, the most common pathogens were P. aeruginosa (12%), S. aureus (12%), CNS (lo%), Cundida spp. (lo%), Enterobacter spp. (9%) and enterococci (9%). Over this period there was an increase in Grampositive organisms, particularly CNS. Small increases in the number of S. aureus, P. aeruginosa, enterococci and Enterobacter spp. also occurred. More recent data from the NNIS study indicate a further increase in CNS (from 9% in 1989 to 30% in 1992). The five leading pathogens isolated from different infection sites in the ICU are shown in Table 2 [ll].
In EPIIC, the most commonly reported pathogens in the ICU were S. aureus, P. aeruginosa, CNS, E. coli, enterococci, Acinetobacter spp., Mebsiellu spp., streptococci and Candida spp. In other epidemiologcal studies, Candida spp. has also been reported as a significant pathogen [38] . As in the NNIS study, the distribution and frequency of pathogens in EPIIC varied depending on the infection site. In the ICU, the main source of infection was from the respiratory tract since most patients were on assisted ventilation.
EPIIC revealed a relatively low rate of laboratorycodinned bloodstream infections, which is in contrast to other studies [39] . Gram-positive organisms accounted for about 70% of the total number of isolates responsible for bacteremia. O f these, CNS accounted and Infection, Volume 3 Supplement 1, A p r i l 1997 for 45% of isolates, followed by S . aureus (21.9%) and enterococci (10.9%). The EPIIC study confirmed the results of other studies that have documented an increasing number of Gram-positive infections, particularly CNS. Enterobacteriaceae and P. aertcginosa were also a frequent cause of bacteremia.
These results are in keeping with those of a retrospective study [lo] , examining trends in the prevalence of causative pathogens for nosocomial bloodstream infections at a single institution in a US referral hospital. Figure 2 shows that the rates of isolation of CNS (p < 0.001), enterococci (p < 0.001), Candida spp. (p = 0.001) and to a lesser extent, S. aureus (p = 0.009), increased between 1981 and 1992. There was also a linear increase in the number of polymicrobial infections. In contrast, the proportion of infections caused by Gram-negative bacilli, such as E. coli, Klebsiella spp., P. aeruginosa, Enterobacter spp. and S. marcescens decreased from 52% in 1980 to 29% in 1992. The proportion of E. coli isolates halved (from 13% to 6.5%) and P. aeruginosa isolates fell from 12% to 5%. The increase in Gram-positive isolates from 42% to 54% does not appear particularly marked until W o l f f : The c h a n g i n g e p i d e m i o l o g y of severe i n f e c t i o n s i n t h e ICU 
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Secular trends in the rates of isolation of selected bloodstream isolates. From Pittet and Wenzel [lo] . With permission of the American Medical Association it is realised that the total number of pathogens isolated in 1990-1992 (1,291) was almost twice that isolated in 1981-1983 (663) . The actual number of Gram-positive cocci bloodstream isolates increased 2.5-fold, whereas the number of isohtes of aerobic Gram-negative bacilli remained constaint. Similarly, a large study of 980 episodes of bacteremia recorded between 1979 and 1989 at a 1,300-bed university hospital in Berlin, showed that bacteremia due to Gram-negative organisms decreased consistently from 45% in 1979 to 39.8% in 1989. In contrast, bacteremia due to Gram-positive bacteria decreased from 47.3% in 1979 to 43.7% in 1986, but increased again to 51.2% in 1989 [40] . The two major pathogens responsible for the increase in numbers of Gram-positive cocci isolated are CNS and enterococci.
Coagulase-negative staphylococci (CNS)
The greater recognition and reporting of CNS as clinically relevant pathogens, together with routine blood cultures are thought to be contributory factors to their increase in incidence [10, 41, 42] . However, controversy exists over whether CNS are true pathogens or merely contaminants of blood cultures.
CNS bacteremia has been shown to have an attributable mortality of 13.6% which, although lower than that for candidemia (36%) and enterococcal bacteremia (31%), is still in excess of that due to underlying disease alone [43] . However, in a recent multicenter study of bacteremia and severe sepsis in adults, Gram-positive organisms other than CNS were among factors which increased the risk of death, indicating that CNS are associated with low pathogenicity [13] .
It has been recommended that two consecutive blood cultures from which CNS are isolated are required before this organism is recognized as the causative pathogen, whereas other reports have indicated that a single blood culture positive for CNS is frequently associated with clinically relevant episodes of bloodstream infection [29, 44] . Henvaldt et al. used four criteria to define true bloodstream infections after isolation of CNS: temperature of 2 38°C; administration of appropriate treatment; criteria for nosocomial bloodstream infection were met; at least one clinical sign or laboratory value consistent with infection [45] . Only 60 (26.4%) of 227 episodes met these stringent criteria. While it is commonly recognized that patients admitted to the ICU may be at increased risk of developing CNS bloodstream infection, only 7.7% of the episodes involving a positive Isolator@ culture from the surgical ICU met the definition of infection. This may, however, have been due to the fact that most of the Isolator@ cultures were actually surveillance cultures performed to study catheter-associated infection and represent a major bias [44] .
Enterococci
Enterococci are also significant nosocomial pathogens, being isolated with increasing frequency in the ICU and the incidence of vancomycin resistance among enterococci is also increasing [10, 11, 25] . Results from the NNIS survey in 1992, found that enterococci were responsible for 15.8% of surgical wound infections, 13% of urinary tract infections and 12% of blood infections [ll] . The clinical significance of enterococcal bacteremia not associated with endocarditis has been controversial. However, it is now agreed that enterococcal isolates fiom the blood may be predictive of high mortality. Moreover, a significant association between appropriate antibiotic therapy and reduced mortality has been shown [46] . The attributable mortality from nosocomial bacteremia was estimated to be 32% in a matched case-control study. In addition, mortality has been recently shown to be higher among bacteremic patients infected with Enterococcus faecium than among those infected with E. faecalis [47] . A recent case-control study, suggests that vancomycin-resistant bacteremia is associated with high rates of severe sepsis and septic shock. In this study the mortality attributable to vancomycin-resistant enterococci (VRE) was 37% (95% confidence interval, 10-64%) [48] .
Emerging pathogens
Several organisms are emerging as nosocomial pathogens and may establish themselves as serious causes of infection [25, 38] . Many institutions report Stenotrophomonas maltophilia, Acinetobacter spp. and Candida spp. as significant pathogens [10, 25, 38] . Acinetobacter spp. have been implicated in a variety of nosocomial infections, but mostly in nosocomial pneumonia. Nosocomial candidemia has become an important infection because of both an apparent increasing incidence and a high fatality rate. The excess mortality attributable to candidemia has been estimated at 38% [34] , and it is k=commended that all patients with candidemia receive antifungal therapy [49] . The main risk factors for nosocomial candidemia in non-neutropenic patients are: recent use of antibiotics; presence of a central venous catheter; hyperalimentation; abdominal and thoracic surgery; and recent use of corticosteroids. The prevalence of Candida non-albicans seems to be increasing. Indeed, in a recent study it was found that Candida non-albicans represented 77% of the 73 episodes of candidemia at hospitals where azoles were rarely used [38] .
Severe sepsis and septic shock
The classification of severe infection-related syndromes has been recently revised to better categorize the patients affected and reflect the range of severity encountered [50, 51] . Patients with a combination of fever or hypothennia, tachycardia, tachypnea or changes in blood leukocyte count that can be attributed to a documented infectious process are now defined as having a clinical syndrome of 'systemic inflammatory response' or SIRS [39] . More severe cases are characterized by the combination of sepsis with signs of organ dysfunction, whde 'septic shock' refers to septic patients with persisting hypotension and/or organ dysfunction despite adequate resuscitation; these conditions are associated with mortality rates ranging from 30-60%.
In a parallel study of 85,750 adrmssions to ICUs and wards of 24 hospitals in France [13] , the rate of bacteremia was 9.8/1000 admissions, and that of severe sepsis 6/1000. Bacteremia was eight times more s43 frequent in ICUs (69/1000) than in wards (8.2/1000) and severe sepsis 32 times higher (119/1000 vs. 2.9/1000). Nosocomial episodes occurred in 41/1000 ICU patients, and bacteremia was associated with severe sepsis in two thirds of episodes. In ICUs, the occurrence of severe sepsis during bacteremia was associated with age, the admission category and the source of bacteremia (with a reduced risk in patients with primary or catheter-related bacteremia, or due to CNS). The risk factor for death after bacteremia increased with age, a rapidly or ultimately fatal underlying disease and the presence of severe sepsis, shock and infection caused by Gram-positive organisms other than CNS ( Table 3) .
A two month prospective study examined the incidence, risk factors and outcome of severe sepsis in ICU patients [9] , and included more than 11,000 admissions to 170 ICUs. Of these patients, 1052 had clinically-suspected severe sepsis which represented 9% of ICU admissions, and severe sepsis with associated microbiological documentation was found in 6.3%. In this study, 48% of the infections were communityacquired and 52% were nosocomial, including 25% ICU-acquired episodes. The predominant sources of infection were pulmonary and abdominal. Risk factors associated with documented severe sepsis were: age (> 60 years); hospital size (> 400 beds); unscheduled admissions; chronic liver failure; immunosuppression and rapidly fatal or ultimately fatal underlying disease. The crude 28-day mortality rate in patients with documented severe sepsis or septic shock was 56%, and that in patients with culture-negative sepsis was similar, 60%. Overall, patients with clinically-suspected severe sepsis had similar risk factors and mortality rates whether or not there was a documented infection.
Distribution of pathogens
In severe sepsis and septic shock, significant differences occur in the frequency of isolation of pathogens in community-acquired and hospitalacquired infection @ < 0.001) (Table 4 ). Overall, the proportion of infections caused by Gram-negative bacilli and the proportion of polymicrobial infections were higher for patients with ICU-acquired sepsis than those with severe sepsis on admission to the ICU. Patients with hospital-acquired sepsis had a higher When specific organisms were substituted and sources of infection were not used in the analysis, risk factors for mortality were: age (p < 0.001);
underlying disease (p < 0,001); nosocomial infection (OR = 1.3; p = 0.04); bacteremia caused by S. aureus (OR = 1.6; p = 0.005) or by Gram-positive organisms other than coagulase negative staphylococci (OR = 1.4; p = 0.04). polymicrobial bacteremia (OR = 1.8; p = 0.008) relative to other organisms.
prevalence of isolation of P. aeruginosa (13.5%), Enterobacteriaceae (31.8%) and CNS (4.7%) than patients with community-acquired sepsis (4.9%, 27.3% and 2. I%, respectively). Conversely, S. pneurnoniae and anaerobes were isolated more frequently from patients with community-acquired severe sepsis. For patients with bacteremia, 39% had Gram-positive infections, 35% had Gram-negative infections and 21% had polymicrobial infections. In the hospital survey, Gram-positive and Gram-negative organisms accounted for 49% and 42% of episodes of bacteremia, respectively, while 5% were mixed-organism bacteremias. The predominant pathogens were S. aweus (19% of episodes), CNS (11%) and enterococci (5.5%). The high frequency of Gram-positive organisms in patients with sepsis syndrome was confirmed in two recent studies of the efficacy of monoclonal antibody to human tumor necrosis factor alpha [52, 53] . In both studies, Gram-positive organisms were nearly as fkequent as Gram-negative organisms and the percentage of patients with mixed pathogens ranged from 10.3-21%, according to the studies and treatment (Table 5 ). This contrasts with earlier studies in which Gram-negative bacteria were the predominant pathogens in the blood Some studies have also found that sepsis can be associated with negative blood cultures. In one study, mortality along SIRS was examined in more than 3700 patients at a single center [55] . As the population progressed from sepsis to septic shock, an increasing proportion of patients developed acute respiratory distress syndrome, disseminated intravascular coagulation, acute renal failure and shock. Positive blood cultures were found in 17% of patients with sepsis, in 25% with severe sepsis and in 69% with septic shock. Mortality in sepsis appeared to be lower (541. Table 5 Distribution of causative organisms in two recent controlled trials of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Selected from Abraham et al. 1995; Cohen & Carlet 1996 [52,53] Norasept (n = 725)a in patients with negative blood cultures than in those with positive blood cultures (10% vs. 16%), but the difference was not statistically significant. There was no difference, however, in mortality between septic shock with or without positive blood cultures in this study, a finding observed in other studies [13, 56, 57] . Importantly, about 50% of the patients with severe sepsis or septic shock had a negative blood culture [13, 57] and mortality rates in patients with septic shock with or without positive blood cultures were similar in most studies [6,13,54-581. 
CONCLUSIONS
Although the major pathogens responsible for hospital-acquired infections vary depending on the site of infection, the results from these studies confirm that S . nureus, E . coli and P. neruxinosa rernain important iiosocomial pathogens and that CNS and enterococci are pathogens of growing importance. The increasing incidence of Grain-positive isolates found in such studies emphasizes the need for broadspectrum antimicrobial agents to be equally effective against Gram-positive and Gram-negative bacteria when empirical antibiotic therapy in severe infections in ICU patients is considered. Several studies have indicated that severe and frequently fatal septic conditions are commonly associated with negative blood cultures, forcing the clinician to start empirical antimicrobial therapy based on individual experieiice and knowledge of the local epidemiological trends.
